Studies have highlighted the potential therapeutic role of sgp130 in treating inflammation; it has been shown to suppress the severity of experimentally-induced arthritis, modulate leukocyte trafficking, and mitigate the effects of colitis and colon cancer [18,40,52-54]. The gene discussed is IL6ST; the disease is malignant colon neoplasm.